Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy

被引：0
|
作者：
Kefang Liu
Shuguang Tan
Yan Chai
Danqing Chen
Hao Song
Catherine Wei-Hong Zhang
Yi Shi
Jun Liu
Wenjie Tan
Jianxin Lyu
Shan Gao
Jinghua Yan
Jianxun Qi
George F Gao
机构：
[1] College of Laboratory Medicine and Life Sciences,
[2] Wenzhou Medical University,undefined
[3] National Institute for Viral Disease Control and Prevention,undefined
[4] Chinese Center for Disease Control and Prevention (China CDC),undefined
[5] CAS Key Laboratory of Pathogenic Microbiology and Immunology,undefined
[6] Institute of Microbiology,undefined
[7] Chinese Academy of Sciences,undefined
[8] Research Network of Immunity and Health (RNIH),undefined
[9] Beijing Institutes of Life Science,undefined
[10] Chinese Academy of Sciences,undefined
[11] ImmuFucell Biotechnology Co.,undefined
[12] Ltd.,undefined
[13] CAS Key Laboratory of Bio-medical Diagnostics,undefined
[14] Suzhou Institute of Biomedical Engineering and Technology,undefined
[15] Chinese Academy of Sciences,undefined
[16] CAS Key Laboratory of Microbial Physiological and Metabolic Engineering,undefined
[17] Institute of Microbiology,undefined
[18] Chinese Academy of Sciences,undefined
来源：
Cell Research | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：151 / 153
页数：2
相关论文
共 50 条
  • [1] Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
    Liu, Kefang
    Tan, Shuguang
    Chai, Yan
    Chen, Danqing
    Song, Hao
    Zhang, Catherine Wei-Hong
    Shi, Yi
    Liu, Jun
    Tan, Wenjie
    Lyu, Jianxin
    Gao, Shan
    Yan, Jinghua
    Qi, Jianxun
    Gao, George F.
    CELL RESEARCH, 2017, 27 (01) : 151 - 153
  • [2] Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
    Qi, J.
    Gao, G. F.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S171 - S171
  • [3] Product review: avelumab, an anti-PD-L1 antibody
    Collins, Julie M.
    Gulley, James L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 891 - 908
  • [4] Avelumab, an anti-PD-L1 monoclonal antibody, shows activity in various tumour types
    Kotsakis, Athanasios
    Georgoulias, Vassilis
    LANCET ONCOLOGY, 2017, 18 (05): : 556 - 557
  • [5] Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
    Zhang, Fei
    Qi, Xiaoqiang
    Wang, Xiaoxiao
    Wei, Diyang
    Wu, Jiawei
    Feng, Lingling
    Cai, Haiyan
    Wang, Yugang
    Zeng, Naiyan
    Xu, Ting
    Zhou, Aiwu
    Zheng, Ying
    ONCOTARGET, 2017, 8 (52) : 90215 - 90224
  • [6] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
  • [7] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Chen, Jiming
    Yang, Jie
    Wang, Wenhui
    Guo, Danfeng
    Zhang, Chengyan
    Wang, Shibo
    Lu, Xinliang
    Huang, Xiaofang
    Wang, Pingli
    Zhang, Gensheng
    Zhang, Jing
    Wang, Jianli
    Cai, Zhijian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1290 - 1301
  • [8] Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
    Donahue, Renee N.
    Lepone, Lauren M.
    Grenga, Italia
    Jochems, Caroline
    Fantini, Massimo
    Madan, Ravi A.
    Heery, Christopher R.
    Gulley, James L.
    Schlom, Jeffrey
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [9] Avelumab, an anti-PD-L1 monoclonal antibody, shows activity in various tumour types (vol 18, pg 556, 2017)
    Kotsakis, A.
    Avelumab, Georgoulias V.
    LANCET ONCOLOGY, 2017, 18 (08): : E433 - E433
  • [10] Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054
    Carpenito, Carmine
    Li, Yiwen
    Wang, George X.
    Malabunga, Maria S.
    Haidar, Jaafar N.
    Forest, Amelie
    Murphy, Mary Y.
    Hall, Gerald E.
    Wang, Cindy
    Shen, Leyi
    Sonyi, Andreas
    Chin, Darin
    Pennello, Anthony L.
    Inigo, Ivan V.
    Surguladze, David
    Yao, Yung-mae
    Burtrum, Douglas
    Novosiadly, Ruslan D.
    Persaud, Kris
    Ludwig, Dale L.
    Kalos, Michael D.
    CANCER RESEARCH, 2018, 78 (13)
12345